Tag: complete blood count device market forecast

  • Complete Blood Count Device Market Projected For Strong Expansion Through 2030: Key Trends And Future Outlook

    Complete Blood Count Device Market Projected For Strong Expansion Through 2030: Key Trends And Future Outlook

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Complete Blood Count Device Market Forecast: Value Set To Climb From $4.58 Billion To $5.76 Billion

    The market for complete blood count devices has shown robust expansion in size over recent years. This market is forecast to increase from $4.33 billion in 2025 to $4.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. The historical growth can be primarily ascribed to the expansion of clinical diagnostic testing volumes, heightened automation in hospital laboratories, the increasing burden of chronic diseases, the widespread availability of standardized blood testing protocols, and a rising demand for routine health screenings.

    The complete blood count device market is anticipated to undergo significant expansion in the coming years. Its valuation is projected to reach $5.76 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This market expansion throughout the forecast period stems from factors such as the increasing integration of decentralized diagnostics, heightened investments in intelligent laboratory infrastructure, an escalating need for swift diagnostic outcomes, the broadening scope of preventive healthcare screenings, and continuous progress in hematology technology. Noteworthy trends for the forecast duration encompass the increasing deployment of automated hematology analyzers, an escalating requirement for point-of-care complete blood count devices, the expanding incorporation of AI-driven diagnostics, the growth of high-throughput laboratory systems, and a more pronounced focus on diagnostic precision and speed.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=62990736&type=smp&name=Complete%20Blood%20Count%20Device%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Complete Blood Count Device Market Development Factors: What’s Supporting Demand?

    The increasing occurrence of blood disorders is anticipated to boost the expansion of the complete blood count device market. These conditions are health issues that interfere with the production, operation, or structure of blood cells, leading to compromised blood function. The uptick in blood disorders is connected to the rising incidence of lifestyle-related ailments, where factors like inadequate diet, lack of physical activity, and stress contribute to issues such as anemia and blood clotting problems. A complete blood count (CBC) device assists in detecting blood disorders through the examination of vital blood components and the identification of irregularities, enabling medical professionals to spot clotting conditions and provide swift and accurate treatment. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based organization, 4,100 individuals were diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Consequently, the rising prevalence of blood disorders is fueling the growth of the complete blood count device market.

    Complete Blood Count Device Market Segment Outlook: Which Categories Are Growing Fastest?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    Complete Blood Count Device Market Transformation Trends: What Innovations Are Driving Change?

    Leading companies in the complete blood count device market are concentrating on creating advanced products, such as compact hematology analyzers, to offer more precise, quicker, and economical solutions for point-of-care testing. Compact hematology analyzers are mobile, simple-to-use instruments that deliver fast, accurate complete blood count (CBC) outcomes with minimal sample volume, rendering them ideal for point-of-care applications, thereby boosting diagnostic precision, operational effectiveness, and user convenience while remaining cost-efficient and straightforward to maintain. For example, in June 2024, HORIBA, a Japan-based analytical and measurement technology firm, unveiled the Yumizen H550E and H500E hematology analyzers. These compact instruments incorporate erythrocyte sedimentation rate (ESR) testing alongside complete blood count (CBC) and 5-part differential (DIFF) analysis, employing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide thorough results from whole blood samples in just 60 seconds.

    Complete Blood Count Device Market Top Companies Driving Competitive Growth

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    View The Full Complete Blood Count Device Market Report:

    https://thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Complete Blood Count Device Market Global Footprint: Which Region Leads The Industry?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Complete Blood Count Device Market Trends Are Creating New Opportunities For Industry Leaders

    Complete Blood Count Device Market Trends Are Creating New Opportunities For Industry Leaders

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    The complete blood count device market has been witnessing steady expansion recently, driven by advancements in diagnostic technologies and a growing need for efficient healthcare solutions. With rising investments and innovations, this sector is set to experience notable growth over the coming years. Let’s explore the market size, key drivers, segmentation, emerging trends, major players, and regional outlook to understand its future trajectory.

    Overview of Market Size and Growth Prospects for Complete Blood Count Devices

    The market for complete blood count devices has seen substantial growth, with its value rising from $4.33 billion in 2025 to an estimated $4.58 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.0%. This expansion during the historical period has been driven by increasing clinical diagnostic testing volumes, enhanced automation in hospital laboratories, a growing burden of chronic illnesses, widespread use of standardized blood testing protocols, and a higher demand for routine health check-ups. Looking ahead, the market is projected to reach $5.76 billion by 2030, growing at a CAGR of 5.9%. Factors contributing to this forecast include greater adoption of decentralized diagnostic approaches, increased investments in smart lab infrastructure, demand for rapid test results, expanded preventive healthcare screening, and ongoing advances in hematology technologies. Key trends anticipated during this period encompass the rising use of automated hematology analyzers, growing popularity of point-of-care complete blood count devices, integration of AI-powered diagnostics, expansion of high-throughput laboratory systems, and an intensifying focus on diagnostic accuracy and speed.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    Key Factors Propelling Growth in the Complete Blood Count Device Market

    The increasing incidence of blood disorders stands as a significant driver behind the growth of the complete blood count device market. Blood disorders impact the production, function, or structure of blood cells, leading to compromised blood performance. The rising frequency of lifestyle-related diseases—caused by poor nutrition, inactivity, and stress—has contributed to conditions such as anemia and clotting abnormalities. Complete blood count devices play an essential role in diagnosing these blood disorders by analyzing critical blood components and detecting abnormalities, enabling healthcare providers to identify clotting issues and administer timely, accurate treatment. For example, in May 2024, the Canadian Cancer Society reported that 4,100 Canadians were diagnosed with multiple myeloma, a form of blood cancer, while 1,750 succumbed to the disease, highlighting the growing need for reliable blood analysis tools. This increase in blood disorder prevalence continues to fuel demand for complete blood count devices.

    Additional Market Drivers Supporting Expansion

    Another catalyst for market growth is the ongoing enhancement of laboratory workflows through automation and the incorporation of smart technology. Hospitals and diagnostic centers are upgrading their facilities to accommodate automated, high-throughput hematology analyzers that deliver faster and more precise results. Moreover, rising awareness about preventive healthcare and routine screening programs is encouraging more frequent blood testing, further expanding the market. The shift towards point-of-care testing is also significant, as healthcare providers seek portable, user-friendly devices that enable quicker diagnostics at or near the patient, reducing reliance on centralized labs.

    Access The Complete Complete Blood Count Device Market Report:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Segmentation Breakdown of the Complete Blood Count Device Market

    This market is segmented across several dimensions to provide a detailed understanding of its structure:

    1) Device Types: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, and Hematology Analyzers.

    2) Test Types: Covering White Blood Cell Count (WBC/Leukocyte), WBC Differential Count, Red Blood Cell Count (RBC/Erythrocyte), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), and others.

    3) Technologies: Including Impedance Technology, Laser-Based Technology, Flow Cytometry, and Microscopy.

    4) Distribution Channels: Such as Direct Sales, Online Sales, Third-Party Distributors, and Laboratory Equipment Suppliers.

    5) End-Users: Hospitals, Diagnostic Laboratories, Research Institutes, and other users.

    Further subcategories exist within these segments. For example, Automated Blood Count Analyzers include 3-Part, 5-Part, and 6-Part and above Differential Analyzers, Integrated Hematology Systems, and High-Throughput Lab Analyzers. Manual Analyzers cover Hemocytometers, Microscopes for Manual Differentials, Manual Cell Counters, and Staining Kits. Point-of-Care Devices involve Portable Hematology Analyzers, Handheld CBC Devices, Fingerstick Blood Test Devices, and Rapid Diagnostic CBC Kits. Hematology Analyzers are divided into Low-, Mid-, and High-Volume analyzers, including Veterinary and Reagent-Free models.

    Emerging Trends Shaping Long-Term Demand in the Complete Blood Count Device Market

    Leading companies in this market are focusing on launching advanced, compact hematology analyzers that offer accurate, rapid, and cost-effective solutions suitable for point-of-care testing. These portable devices require minimal sample volumes and provide quick complete blood count results, enhancing diagnostic efficiency and accessibility. Such innovations improve ease of use and maintenance, making them attractive options in various healthcare settings. For instance, in June 2024, HORIBA introduced the Yumizen H550E and H500E analyzers, which integrate erythrocyte sedimentation rate (ESR) testing with CBC and 5-part differential analyses. These devices employ HORIBA’s patented CoRA (correlated rouleaux analysis) technology to deliver comprehensive blood examination results from whole blood samples within 60 seconds.

    Additional Trends Driving Market Innovation

    Apart from miniaturization and speed, the market is witnessing growing integration of artificial intelligence and machine learning within diagnostic tools. AI-based diagnostics enhance the precision and interpretation of hematology results, while high-throughput systems streamline laboratory workflows to handle increasing test volumes efficiently. These technological improvements help laboratories meet rising demand for both routine and specialized blood analysis.

    Competitive Landscape of the Complete Blood Count Device Market

    Key players in the complete blood count device industry include major global companies such as Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (an EKF subsidiary), Analyticon Biotechnologies GmbH, and Rayto Life and Analytical Sciences Co. Ltd. These companies continue to invest in research and development to bring innovative, reliable, and user-friendly devices to the market.

    Regional Perspectives and Growth Opportunities in the Complete Blood Count Device Industry

    In 2025, North America held the largest market share for complete blood count devices, supported by advanced healthcare infrastructure and strong adoption of diagnostic technologies. Meanwhile, the Asia-Pacific region is expected to experience the fastest growth throughout the forecast period. This growth is driven by rising healthcare expenditures, increasing prevalence of chronic and lifestyle diseases, expanding healthcare access, and a growing middle class demanding better diagnostic services. The market report covers critical regions including Asia-Pacific, South East Asia, Western and Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on market trends and regional opportunities.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Complete Blood Count Device Market Insights Exploring Expansion Opportunities Through 2030

    Complete Blood Count Device Market Insights Exploring Expansion Opportunities Through 2030

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Are The Forecasted Market Size Figures For The Complete Blood Count Device Market In 2026 And 2030?

    The complete blood count device market has experienced substantial growth recently. This market is projected to expand from $4.33 billion in 2025 to $4.58 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. Historically, this expansion has been driven by factors such as the increasing volumes of clinical diagnostic testing, enhanced automation in hospital laboratories, the growing prevalence of chronic diseases, the availability of standardized blood testing protocols, and a rising demand for routine health screenings.

    The complete blood count device market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $5.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. Key factors driving this growth during the projected period include the rising acceptance of decentralized diagnostics, increased capital expenditure in advanced laboratory infrastructure, a heightened need for prompt diagnostic outcomes, the broadened scope of preventive healthcare examinations, and ongoing innovations in hematology technology. Significant trends observed during the forecast timeframe encompass the expanding use of automated hematology analyzers, an increasing requirement for point-of-care CBC devices, the growing incorporation of AI-powered diagnostics, the proliferation of high-throughput laboratory systems, and an intensified emphasis on diagnostic precision and quickness.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    Which Growth Drivers Are Expected To Support The Complete Blood Count Device Market Forward?

    The increasing incidence of blood disorders is anticipated to boost the expansion of the complete blood count device market in the future. These disorders are defined as conditions that interfere with the normal production, operation, or formation of blood cells, leading to compromised blood function. The escalation in blood disorders is associated with the rising frequency of lifestyle-related illnesses, where factors like an unhealthy diet, lack of physical activity, and stress contribute to conditions like anemia and problems with blood clotting. A complete blood count (CBC) device assists in the diagnosis of blood disorders through the analysis of essential blood components and the detection of irregularities, enabling medical professionals to pinpoint clotting issues and guarantee timely and accurate treatment. As an illustration, in May 2024, data from the Canadian Cancer Society, an organization based in Canada, indicated that 4,100 individuals received a diagnosis of multiple myeloma (a form of blood cancer), and 1,750 passed away from it. Consequently, the expanding occurrence of blood disorders is fueling the growth of the complete blood count device market.

    How Are Different Segment Groups Identified Within The Complete Blood Count Device Market?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    Which Trends Are Supporting The Evolution Of The Complete Blood Count Device Market?

    Major companies operating in the complete blood count device market are focusing on developing advanced products, such as compact hematology analyzers, to provide more accurate, faster, and cost-effective solutions for point-of-care testing. Compact hematology analyzers are portable, user-friendly devices that deliver quick, accurate complete blood count (CBC) results with minimal sample volume. This makes them ideal for point-of-care use, enhancing diagnostic accuracy, efficiency, and ease of use, while also being cost-effective and simple to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, launched the Yumizen H550E and H500E hematology analyzers. These compact instruments integrate erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, utilizing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.

    Which Organizations Are Involved In The Complete Blood Count Device Market?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Access The Complete Complete Blood Count Device Market Report:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    What Is The Largest Regional Market In The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Complete Blood Count Device Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • The Complete Blood Count Device Market Is Witnessing Impact From The Growing Prevalence Of Blood Disorders Is Fueling The Growth Of The Market Due To Its Impact On Diagnostic Demand

    The Complete Blood Count Device Market Is Witnessing Impact From The Growing Prevalence Of Blood Disorders Is Fueling The Growth Of The Market Due To Its Impact On Diagnostic Demand

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Projected Increase In Market Value Of The Complete Blood Count Device Market During 2026–2030?

    The complete blood count device market has experienced substantial growth in recent years. This market is set to increase from $4.33 billion in 2025 to $4.58 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.0%. Historically, this expansion can be attributed to several factors including the rising volume of clinical diagnostic testing, greater automation in hospital laboratories, the increasing burden of chronic diseases, the presence of standardized blood testing protocols, and the growing demand for routine health screenings.

    The complete blood count device market size is projected to experience substantial expansion in the coming years. It is anticipated to reach $5.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period is primarily driven by factors such as the increasing embrace of decentralized diagnostics, higher investments in smart laboratory infrastructure, the growing need for swift diagnostic outcomes, the broadening scope of preventive healthcare testing, and ongoing progress in hematology technology. Key trends foreseen for the same period encompass the wider use of automated hematology analyzers, a surge in the demand for point-of-care cbc devices, the increasing incorporation of AI-based diagnostics, the proliferation of high-throughput laboratory systems, and a sharpened emphasis on the precision and speed of diagnostics.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    What Factors Are Contributing To The Growth Of The Complete Blood Count Device Market?

    The increasing occurrence of blood-related conditions is anticipated to fuel the expansion of the complete blood count device market. These conditions involve malfunctions in the creation, operation, or formation of blood cells, leading to compromised blood functionality. The escalation of blood disorders is connected to the rising incidence of lifestyle-related illnesses, where factors like unhealthy eating, lack of physical activity, and stress contribute to ailments such as anemia and coagulation problems. A complete blood count (CBC) device assists in the diagnosis of blood conditions through the analysis of vital blood components and the identification of irregularities, enabling medical professionals to detect clotting issues and facilitate timely, accurate treatment. As an illustration, in May 2024, data from the Canadian Cancer Society, a Canada-based organization, revealed that 4,100 individuals received a diagnosis of multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Consequently, the increasing frequency of blood disorders is stimulating the expansion of the complete blood count device market.

    How Is Segmentation Applied In The Complete Blood Count Device Market Segment Analysis?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    What Trends Are Shaping The Future Of The Complete Blood Count Device Market?

    Leading companies within the complete blood count device market are focusing their efforts on creating advanced products, such as compact hematology analyzers, to deliver more precise, faster, and cost-effective solutions for point-of-care testing. Compact hematology analyzers are portable, user-friendly instruments that provide rapid, accurate complete blood count (CBC) results using only a small sample volume, positioning them as ideal for point-of-care applications, improving diagnostic accuracy, efficiency, and user convenience, all while being economical and easy to upkeep. An example of this trend is HORIBA, a Japan-based analytical and measurement technology company, which launched the Yumizen H550E and H500E hematology analyzers in June 2024. These compact devices combine erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, leveraging HORIBA’s patented CoRA (correlated rouleaux analysis) technology to furnish comprehensive results from whole blood samples in just 60 seconds.

    Who Are The Companies Participating In The Complete Blood Count Device Market Environment?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Get The Full Complete Blood Count Device Market Report:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Which Region Has The Greatest Market Share In The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Complete Blood Count Device Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • The Complete Blood Count Device Market Is Witnessing Impact From The Growing Prevalence Of Blood Disorders Is Fueling The Growth Of The Market Due To Its Impact On Diagnostic Demand

    The Complete Blood Count Device Market Is Witnessing Impact From The Growing Prevalence Of Blood Disorders Is Fueling The Growth Of The Market Due To Its Impact On Diagnostic Demand

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Projected Increase In Market Value Of The Complete Blood Count Device Market During 2026–2030?

    The complete blood count device market has experienced substantial growth in recent years. This market is set to increase from $4.33 billion in 2025 to $4.58 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.0%. Historically, this expansion can be attributed to several factors including the rising volume of clinical diagnostic testing, greater automation in hospital laboratories, the increasing burden of chronic diseases, the presence of standardized blood testing protocols, and the growing demand for routine health screenings.

    The complete blood count device market size is projected to experience substantial expansion in the coming years. It is anticipated to reach $5.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period is primarily driven by factors such as the increasing embrace of decentralized diagnostics, higher investments in smart laboratory infrastructure, the growing need for swift diagnostic outcomes, the broadening scope of preventive healthcare testing, and ongoing progress in hematology technology. Key trends foreseen for the same period encompass the wider use of automated hematology analyzers, a surge in the demand for point-of-care cbc devices, the increasing incorporation of AI-based diagnostics, the proliferation of high-throughput laboratory systems, and a sharpened emphasis on the precision and speed of diagnostics.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    What Factors Are Contributing To The Growth Of The Complete Blood Count Device Market?

    The increasing occurrence of blood-related conditions is anticipated to fuel the expansion of the complete blood count device market. These conditions involve malfunctions in the creation, operation, or formation of blood cells, leading to compromised blood functionality. The escalation of blood disorders is connected to the rising incidence of lifestyle-related illnesses, where factors like unhealthy eating, lack of physical activity, and stress contribute to ailments such as anemia and coagulation problems. A complete blood count (CBC) device assists in the diagnosis of blood conditions through the analysis of vital blood components and the identification of irregularities, enabling medical professionals to detect clotting issues and facilitate timely, accurate treatment. As an illustration, in May 2024, data from the Canadian Cancer Society, a Canada-based organization, revealed that 4,100 individuals received a diagnosis of multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Consequently, the increasing frequency of blood disorders is stimulating the expansion of the complete blood count device market.

    How Is Segmentation Applied In The Complete Blood Count Device Market Segment Analysis?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    What Trends Are Shaping The Future Of The Complete Blood Count Device Market?

    Leading companies within the complete blood count device market are focusing their efforts on creating advanced products, such as compact hematology analyzers, to deliver more precise, faster, and cost-effective solutions for point-of-care testing. Compact hematology analyzers are portable, user-friendly instruments that provide rapid, accurate complete blood count (CBC) results using only a small sample volume, positioning them as ideal for point-of-care applications, improving diagnostic accuracy, efficiency, and user convenience, all while being economical and easy to upkeep. An example of this trend is HORIBA, a Japan-based analytical and measurement technology company, which launched the Yumizen H550E and H500E hematology analyzers in June 2024. These compact devices combine erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, leveraging HORIBA’s patented CoRA (correlated rouleaux analysis) technology to furnish comprehensive results from whole blood samples in just 60 seconds.

    Who Are The Companies Participating In The Complete Blood Count Device Market Environment?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Get The Full Complete Blood Count Device Market Report:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Which Region Has The Greatest Market Share In The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Complete Blood Count Device Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • The Complete Blood Count Device Market Is Witnessing Impact From The Growing Prevalence Of Blood Disorders Is Fueling The Growth Of The Market Due To Its Impact On Diagnostic Demand

    The Complete Blood Count Device Market Is Witnessing Impact From The Growing Prevalence Of Blood Disorders Is Fueling The Growth Of The Market Due To Its Impact On Diagnostic Demand

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Projected Increase In Market Value Of The Complete Blood Count Device Market During 2026–2030?

    The complete blood count device market has experienced substantial growth in recent years. This market is set to increase from $4.33 billion in 2025 to $4.58 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.0%. Historically, this expansion can be attributed to several factors including the rising volume of clinical diagnostic testing, greater automation in hospital laboratories, the increasing burden of chronic diseases, the presence of standardized blood testing protocols, and the growing demand for routine health screenings.

    The complete blood count device market size is projected to experience substantial expansion in the coming years. It is anticipated to reach $5.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.9%. This expansion during the forecast period is primarily driven by factors such as the increasing embrace of decentralized diagnostics, higher investments in smart laboratory infrastructure, the growing need for swift diagnostic outcomes, the broadening scope of preventive healthcare testing, and ongoing progress in hematology technology. Key trends foreseen for the same period encompass the wider use of automated hematology analyzers, a surge in the demand for point-of-care cbc devices, the increasing incorporation of AI-based diagnostics, the proliferation of high-throughput laboratory systems, and a sharpened emphasis on the precision and speed of diagnostics.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    What Factors Are Contributing To The Growth Of The Complete Blood Count Device Market?

    The increasing occurrence of blood-related conditions is anticipated to fuel the expansion of the complete blood count device market. These conditions involve malfunctions in the creation, operation, or formation of blood cells, leading to compromised blood functionality. The escalation of blood disorders is connected to the rising incidence of lifestyle-related illnesses, where factors like unhealthy eating, lack of physical activity, and stress contribute to ailments such as anemia and coagulation problems. A complete blood count (CBC) device assists in the diagnosis of blood conditions through the analysis of vital blood components and the identification of irregularities, enabling medical professionals to detect clotting issues and facilitate timely, accurate treatment. As an illustration, in May 2024, data from the Canadian Cancer Society, a Canada-based organization, revealed that 4,100 individuals received a diagnosis of multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Consequently, the increasing frequency of blood disorders is stimulating the expansion of the complete blood count device market.

    How Is Segmentation Applied In The Complete Blood Count Device Market Segment Analysis?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    What Trends Are Shaping The Future Of The Complete Blood Count Device Market?

    Leading companies within the complete blood count device market are focusing their efforts on creating advanced products, such as compact hematology analyzers, to deliver more precise, faster, and cost-effective solutions for point-of-care testing. Compact hematology analyzers are portable, user-friendly instruments that provide rapid, accurate complete blood count (CBC) results using only a small sample volume, positioning them as ideal for point-of-care applications, improving diagnostic accuracy, efficiency, and user convenience, all while being economical and easy to upkeep. An example of this trend is HORIBA, a Japan-based analytical and measurement technology company, which launched the Yumizen H550E and H500E hematology analyzers in June 2024. These compact devices combine erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, leveraging HORIBA’s patented CoRA (correlated rouleaux analysis) technology to furnish comprehensive results from whole blood samples in just 60 seconds.

    Who Are The Companies Participating In The Complete Blood Count Device Market Environment?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Get The Full Complete Blood Count Device Market Report:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Which Region Has The Greatest Market Share In The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Complete Blood Count Device Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Complete Blood Count Device Industry Trends and Market Growth Forecast for 2026–2030

    Global Complete Blood Count Device Industry Trends and Market Growth Forecast for 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Complete Blood Count Device Market By The End Of 2030?

    The complete blood count device market size has experienced robust growth in recent years. Its value is projected to climb from $4.33 billion in 2025 to $4.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.0%. This historical expansion can be attributed to factors such as the increased volumes of clinical diagnostic testing, heightened automation in hospital laboratories, the rising global burden of chronic diseases, the establishment of standardized blood testing protocols, and the growing demand for routine health screenings.

    The complete blood count device market is projected to experience substantial expansion over the upcoming years. It is forecast to reach $5.76 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This anticipated growth is primarily driven by the escalating embrace of decentralized diagnostics, greater capital expenditure in intelligent laboratory frameworks, a heightened need for swift diagnostic outcomes, the broadened scope of preventive healthcare screening, and ongoing innovations within hematology technology. Key developments anticipated during this timeframe encompass the wider deployment of automated hematology analyzers, a surge in the need for point-of-care cbc devices, the increasing incorporation of AI-powered diagnostics, the proliferation of high-throughput laboratory setups, and a magnified emphasis on both the precision and rapidity of diagnostic procedures.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    What Drivers Are Shaping The Future Growth Of The Complete Blood Count Device Market?

    The increasing incidence of blood disorders is anticipated to propel the expansion of the complete blood count device market. These disorders are conditions that interfere with the normal production, operation, or structure of blood cells, leading to compromised blood function. The rise in blood disorders is linked to the growing occurrence of lifestyle diseases, where factors such as inadequate diet, physical inactivity, and stress contribute to conditions like anemia and coagulation issues. A complete blood count (CBC) device aids in diagnosing blood disorders by analyzing essential blood components and identifying abnormalities, thereby allowing healthcare professionals to pinpoint clotting disorders and ensure prompt and precise treatment. For instance, in May 2024, the Canadian Cancer Society, a Canada-based organization, reported 4,100 individuals diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Therefore, the growing prevalence of blood disorders is stimulating the growth of the complete blood count device market.

    Which Segment Classifications Shape The Complete Blood Count Device Market?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    How Are Trends Impacting The Complete Blood Count Device Market?

    Leading companies within the complete blood count device market are focusing on the development of advanced products, such as compact hematology analyzers, to offer more precise, quicker, and economical solutions for point-of-care testing. Compact hematology analyzers are portable and user-friendly instruments that deliver rapid, accurate complete blood count (CBC) results from minimal sample volumes, making them perfect for point-of-care applications by boosting diagnostic accuracy, efficiency, and ease of use, while also being cost-effective and simple to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, unveiled the Yumizen H550E and H500E hematology analyzers. These compact instruments integrate erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, employing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.

    Which Companies Are Expanding Their Footprint In The Complete Blood Count Device Market?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Read the full complete blood count device market report here:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Which Geographic Regions Are Influencing Demand In The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Complete Blood Count Device Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Complete Blood Count Device Industry Trends and Market Growth Forecast for 2026–2030

    Global Complete Blood Count Device Industry Trends and Market Growth Forecast for 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Complete Blood Count Device Market By The End Of 2030?

    The complete blood count device market size has experienced robust growth in recent years. Its value is projected to climb from $4.33 billion in 2025 to $4.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.0%. This historical expansion can be attributed to factors such as the increased volumes of clinical diagnostic testing, heightened automation in hospital laboratories, the rising global burden of chronic diseases, the establishment of standardized blood testing protocols, and the growing demand for routine health screenings.

    The complete blood count device market is projected to experience substantial expansion over the upcoming years. It is forecast to reach $5.76 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This anticipated growth is primarily driven by the escalating embrace of decentralized diagnostics, greater capital expenditure in intelligent laboratory frameworks, a heightened need for swift diagnostic outcomes, the broadened scope of preventive healthcare screening, and ongoing innovations within hematology technology. Key developments anticipated during this timeframe encompass the wider deployment of automated hematology analyzers, a surge in the need for point-of-care cbc devices, the increasing incorporation of AI-powered diagnostics, the proliferation of high-throughput laboratory setups, and a magnified emphasis on both the precision and rapidity of diagnostic procedures.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    What Drivers Are Shaping The Future Growth Of The Complete Blood Count Device Market?

    The increasing incidence of blood disorders is anticipated to propel the expansion of the complete blood count device market. These disorders are conditions that interfere with the normal production, operation, or structure of blood cells, leading to compromised blood function. The rise in blood disorders is linked to the growing occurrence of lifestyle diseases, where factors such as inadequate diet, physical inactivity, and stress contribute to conditions like anemia and coagulation issues. A complete blood count (CBC) device aids in diagnosing blood disorders by analyzing essential blood components and identifying abnormalities, thereby allowing healthcare professionals to pinpoint clotting disorders and ensure prompt and precise treatment. For instance, in May 2024, the Canadian Cancer Society, a Canada-based organization, reported 4,100 individuals diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Therefore, the growing prevalence of blood disorders is stimulating the growth of the complete blood count device market.

    Which Segment Classifications Shape The Complete Blood Count Device Market?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    How Are Trends Impacting The Complete Blood Count Device Market?

    Leading companies within the complete blood count device market are focusing on the development of advanced products, such as compact hematology analyzers, to offer more precise, quicker, and economical solutions for point-of-care testing. Compact hematology analyzers are portable and user-friendly instruments that deliver rapid, accurate complete blood count (CBC) results from minimal sample volumes, making them perfect for point-of-care applications by boosting diagnostic accuracy, efficiency, and ease of use, while also being cost-effective and simple to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, unveiled the Yumizen H550E and H500E hematology analyzers. These compact instruments integrate erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, employing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.

    Which Companies Are Expanding Their Footprint In The Complete Blood Count Device Market?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Read the full complete blood count device market report here:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Which Geographic Regions Are Influencing Demand In The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Complete Blood Count Device Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global Complete Blood Count Device Industry Trends and Market Growth Forecast for 2026–2030

    Global Complete Blood Count Device Industry Trends and Market Growth Forecast for 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Will Be The Estimated Market Valuation Of The Complete Blood Count Device Market By The End Of 2030?

    The complete blood count device market size has experienced robust growth in recent years. Its value is projected to climb from $4.33 billion in 2025 to $4.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.0%. This historical expansion can be attributed to factors such as the increased volumes of clinical diagnostic testing, heightened automation in hospital laboratories, the rising global burden of chronic diseases, the establishment of standardized blood testing protocols, and the growing demand for routine health screenings.

    The complete blood count device market is projected to experience substantial expansion over the upcoming years. It is forecast to reach $5.76 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This anticipated growth is primarily driven by the escalating embrace of decentralized diagnostics, greater capital expenditure in intelligent laboratory frameworks, a heightened need for swift diagnostic outcomes, the broadened scope of preventive healthcare screening, and ongoing innovations within hematology technology. Key developments anticipated during this timeframe encompass the wider deployment of automated hematology analyzers, a surge in the need for point-of-care cbc devices, the increasing incorporation of AI-powered diagnostics, the proliferation of high-throughput laboratory setups, and a magnified emphasis on both the precision and rapidity of diagnostic procedures.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    What Drivers Are Shaping The Future Growth Of The Complete Blood Count Device Market?

    The increasing incidence of blood disorders is anticipated to propel the expansion of the complete blood count device market. These disorders are conditions that interfere with the normal production, operation, or structure of blood cells, leading to compromised blood function. The rise in blood disorders is linked to the growing occurrence of lifestyle diseases, where factors such as inadequate diet, physical inactivity, and stress contribute to conditions like anemia and coagulation issues. A complete blood count (CBC) device aids in diagnosing blood disorders by analyzing essential blood components and identifying abnormalities, thereby allowing healthcare professionals to pinpoint clotting disorders and ensure prompt and precise treatment. For instance, in May 2024, the Canadian Cancer Society, a Canada-based organization, reported 4,100 individuals diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Therefore, the growing prevalence of blood disorders is stimulating the growth of the complete blood count device market.

    Which Segment Classifications Shape The Complete Blood Count Device Market?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    How Are Trends Impacting The Complete Blood Count Device Market?

    Leading companies within the complete blood count device market are focusing on the development of advanced products, such as compact hematology analyzers, to offer more precise, quicker, and economical solutions for point-of-care testing. Compact hematology analyzers are portable and user-friendly instruments that deliver rapid, accurate complete blood count (CBC) results from minimal sample volumes, making them perfect for point-of-care applications by boosting diagnostic accuracy, efficiency, and ease of use, while also being cost-effective and simple to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, unveiled the Yumizen H550E and H500E hematology analyzers. These compact instruments integrate erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, employing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.

    Which Companies Are Expanding Their Footprint In The Complete Blood Count Device Market?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Read the full complete blood count device market report here:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Which Geographic Regions Are Influencing Demand In The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Complete Blood Count Device Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Complete Blood Count Device Market Forecast 2026–2035: How to Leverage Market Growth

    Complete Blood Count Device Market Forecast 2026–2035: How to Leverage Market Growth

    Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

    What growth pattern is forecast for the Complete Blood Count Device Market size between 2026 and 2035?

    The complete blood count device market has experienced robust expansion over recent years. Projections indicate it will expand from $4.33 billion in 2025 to $4.58 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.0%. Historically, this growth is primarily due to factors such as the expansion of clinical diagnostic testing volumes, increased hospital laboratory automation, the growing burden of chronic diseases, the availability of standardized blood testing protocols, and a rising demand for routine health screenings.

    The complete blood count device market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $5.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.9%. This projected growth stems from factors such as the greater embrace of decentralized diagnostics, increased funding for intelligent laboratory setups, a rising need for swift diagnostic outcomes, the broadening scope of preventive health screenings, and ongoing progress in hematology technology. Key developments expected during this forecast timeframe encompass the wider use of automated hematology analyzers, an escalating requirement for point-of-care CBC devices, the increasing incorporation of AI-powered diagnostics, the proliferation of high-throughput laboratory systems, and a sharpened emphasis on diagnostic precision and rapidity.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24195&type=smp

    Which Drivers Are Impacting Market Performance In The Complete Blood Count Device Market?

    The increasing incidence of blood disorders is anticipated to fuel the expansion of the complete blood count device market in the future. These conditions involve disruptions in the formation, operation, or makeup of blood cells, leading to compromised blood functionality. The escalation in blood disorders is connected to the rising frequency of lifestyle-related illnesses, where factors like an unhealthy diet, lack of physical activity, and stress contribute to ailments like anemia and problems with blood clotting. A complete blood count (CBC) device assists in the diagnosis of blood disorders by examining crucial blood constituents and identifying irregularities, thereby enabling medical practitioners to pinpoint clotting issues and guarantee swift, accurate treatment. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based organization, 4,100 individuals were diagnosed with multiple myeloma (a type of blood cancer), while 1,750 succumbed to the disease. Consequently, the expanding occurrence of blood disorders is stimulating the growth of the complete blood count device market.

    What Segment Types Are Examined In The Complete Blood Count Device Market?

    The complete blood count device market covered in this report is segmented –

    1) By Device Type: Automated Blood Count Analyzers, Manual Blood Count Analyzers, Point-Of-Care Testing Devices, Hematology Analyzers

    2) By Test Type: White Blood Cell Count (WBC Or Leukocyte Count), White Blood Cell (WBC) Differential Count, Red Blood Cell Count (RBC Or Erythrocyte Count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), Other Test Types

    3) By Technology: Impedance Technology, Laser-Based Technology, Flow Cytometry, Microscopy

    4) By Distribution Channel: Direct Sales, Online Sales, Third-Party Distributors, Laboratory Equipment Suppliers

    5) By End-User: Hospital, Diagnostic Laboratories, Research Institutes, Other End-Users

    Subsegments:

    1) By Automated Blood Count Analyzers: 3-Part Differential Analyzers, 5-Part Differential Analyzers, 6-Part And Above Differential Analyzers, Integrated Hematology Systems, High-Throughput Lab Analyzers

    2) By Manual Blood Count Analyzers: Hemocytometers, Microscopes For Manual Differential, Manual Cell Counters, Staining Kits And Reagents

    3) By Point-of-Care Testing Devices: Portable Hematology Analyzers, Handheld Complete Blood Count (CBC) Devices, Fingerstick Blood Test Devices, Rapid Diagnostic Complete Blood Count (CBC) Kits

    4) By Hematology Analyzers: Low-Volume Hematology Analyzers, Mid-Volume Hematology Analyzers, High-Volume Hematology Analyzers, Veterinary Hematology Analyzers, Reagent-Free Analyzers

    What Industry Trends Are Transforming The Complete Blood Count Device Market?

    Leading companies in the complete blood count device market are concentrating on creating advanced products, such as compact hematology analyzers, to offer more precise, rapid, and economical solutions for point-of-care testing. Compact hematology analyzers are portable and easy-to-use instruments that deliver quick, accurate complete blood count (CBC) results with minimal sample volume, positioning them as ideal for point-of-care applications. This enhances diagnostic accuracy, efficiency, and user-friendliness while remaining cost-effective and simple to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, introduced its Yumizen H550E and H500E hematology analyzers. These compact devices merge erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, utilizing HORIBA’s patented CoRA (correlated rouleaux analysis) technology to provide comprehensive results from whole blood samples in just 60 seconds.

    Who Are The Prominent Global Companies Shaping The Complete Blood Count Device Market Landscape?

    Major companies operating in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd., Roche Diagnostics, Ortho Clinical Diagnostics, BioSystems Diagnostics Pvt. Ltd., Drew Scientific (subsidiary of EKF), Analyticon Biotechnologies GmbH, Rayto Life and Analytical Sciences Co. Ltd.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/complete-blood-count-device-global-market-report

    Which Geographic Areas Are Emerging As Strong Markets For The Complete Blood Count Device Market?

    North America was the largest region in the complete blood count device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complete blood count device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Complete Blood Count Device Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=24195&type=smp

    Browse Through More Reports Similar to the Global Complete Blood Count Device Market 2026, By The Business Research Company

    Clinical Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Oncology Companion Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

    Nuclear Medicine Diagnostics Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company